Taltz belongs to a group of drugs known as interleukin (IL) inhibitors. It is a humanized interleukin-17A antagonist indicated for the treatment of moderate-to-severe plaque psoriasis and also active psoriatic arthritis. This product is supplied as a prefilled syringe. The manufacturer of this product is Eli Lilly, a pharmaceutical company.
What is it made of?
Ixekizumab is the active ingredient of Taltz. This product is produced by recombinant deoxyribonucleic acid (DNA) technology. Taltz is a clear, colorless to slightly yellow solution.
What are its uses?
Taltz is indicated for active psoriatic arthritis in adult patients. This product also treats adults with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
How long do its effects last?
This product has an elimination half-life of around thirteen days.